This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, Hoenigl M. COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of ımmunological predispositions? J Fungi (Basel). 2020 Oct 8;6(4):211. https://doi.org/10.3390/jof6040211ArastehfarACarvalhoANguyenMHHedayatiMTNeteaMGPerlinDSHoeniglMCOVID-19-associated candidiasis (CAC): An underestimated complication in the absence of ımmunological predispositions?J Fungi (Basel)2020Oct 864211https://doi.org/10.3390/jof604021110.3390/jof6040211771298733050019Search in Google Scholar
Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID- 19 associated pulmonary aspergillosis (CAPA) – from immunology to treatment. J Fungi (Basel). 2020a;6(2):91. https://doi.org/10.3390/jof6020091ArastehfarACarvalhoAvande Veerdonk FLJenksJDKoehlerPKrauseRCornelyOASPerlin DLass-FlörlCHoeniglMCOVID- 19 associated pulmonary aspergillosis (CAPA) – from immunology to treatmentJ Fungi (Basel)2020a6291https://doi.org/10.3390/jof602009110.3390/jof6020091734600032599813Search in Google Scholar
Arastehfar A, Shaban T, Zarrinfar H, Roudbary M, Ghazanfari M, Hedayati MT, Sedaghat A, Ilkit M, Najafzadeh MJ, Perlin DS. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi (Basel). 2021 Apr 08;7(4):280. https://doi.org/10.3390/jof7040280ArastehfarAShabanTZarrinfarHRoudbaryMGhazanfariMHedayatiMTSedaghatAIlkitMNajafzadehMJPerlinDSCandidemia among Iranian patients with severe COVID-19 admitted to ICUsJ Fungi (Basel)2021Apr 0874280https://doi.org/10.3390/jof704028010.3390/jof7040280806836333917967Search in Google Scholar
Bastos GAN, Azambuja AZ, Polanczyk CA, Gräf DD, Zorzo IW, Maccari JG, Haygert LS, Nasi LA, Gazzana MB, Bessel M, et al. Clinical characteristics and predictors of mechanical ventilation in patients with COVID- 19 hospitalized in Southern Brazil. Rev Bras Ter Intensiva. 2020 Oct-Dec;32(4):487–492. https://doi.org/10.5935/0103-507X.20200082BastosGANAzambujaAZPolanczykCAGräfDDZorzoIWMaccariJGHaygertLSNasiLAGazzanaMBBesselMet alClinical characteristics and predictors of mechanical ventilation in patients with COVID- 19 hospitalized in Southern BrazilRev Bras Ter Intensiva2020Oct-Dec324487492https://doi.org/10.5935/0103-507X.2020008210.5935/0103-507X.20200082785367333263703Search in Google Scholar
Binelli CA, Moretti ML, Assis RS, Sauaia N, Menezes PR, Ribeiro E, Geiger DCP, Mikami Y, Miyaji M, Oliveira MS, et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect. 2006 Jun;12(6):538–543. https://doi.org/10.1111/j.1469-0691.2006.01435.xBinelliCAMorettiMLAssisRSSauaiaNMenezesPRRibeiroEGeigerDCPMikamiYMiyajiMOliveiraMSet alInvestigation of the possible association between nosocomial candiduria and candidaemiaClin Microbiol Infect2006Jun126538543https://doi.org/10.1111/j.1469-0691.2006.01435.x10.1111/j.1469-0691.2006.01435.x16700702Search in Google Scholar
Bishburg E, Okoh A, Nagarakanti SR, Lindner M, Migliore C, Patel P. Fungemia in COVID- 19 ICU patients, a single medical center experience. J Med Virol. 2021 May;93(5):2810–2814. https://doi.org/10.1002/jmv.26633BishburgEOkohANagarakantiSRLindnerMMiglioreCPatelPFungemia in COVID- 19 ICU patients, a single medical center experienceJ Med Virol2021May93528102814https://doi.org/10.1002/jmv.2663310.1002/jmv.2663333107617Search in Google Scholar
Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April–July 2020. Emerg Infect Dis. 2020 Nov;26(11):2694–2696. https://doi.org/10.3201/eid2611.203504ChowdharyATaraiBSinghASharmaAMultidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April–July 2020Emerg Infect Dis2020Nov261126942696https://doi.org/10.3201/eid2611.20350410.3201/eid2611.203504758854732852265Search in Google Scholar
CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard – Third edition. CLSI document M27-A. Wayne (USA): Clinical and Laboratory Standards Institute; 2008.CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard – Third edition. CLSI document M27-AWayne (USA)Clinical and Laboratory Standards Institute;2008Search in Google Scholar
Coşkun AS, Durmaz ŞÖ. Fungal infections in COVID- 19 intensive care patients. Pol J Microbiol. 2021 Sep 01;70(3):395–400. https://doi.org/10.33073/pjm-2021-039CoşkunASDurmazŞÖFungal infections in COVID- 19 intensive care patientsPol J Microbiol2021Sep 01703395400https://doi.org/10.33073/pjm-2021-03910.33073/pjm-2021-039845900134584533Search in Google Scholar
da Silva RB, Neves RP, Hinrichsen SL, de Lima-Neto RG. Candidemia in a public hospital in Northeastern Brazil: Epidemiological features and risk factors in critically ill patients. Rev Iberoam Micol. 2019 Oct-Dec;36(4):181–185. https://doi.org/10.1016/j.riam.2019.06.003daSilva RBNevesRPHinrichsenSLdeLima-Neto RGCandidemia in a public hospital in Northeastern Brazil: Epidemiological features and risk factors in critically ill patientsRev Iberoam Micol2019Oct-Dec364181185https://doi.org/10.1016/j.riam.2019.06.00310.1016/j.riam.2019.06.00331759839Search in Google Scholar
Drogari-Apiranthitou M, Anyfantis I, Galani I, Kanioura L, Daikos GL, Petrikkos G. Association between candiduria and candidemia: A clinical and molecular analysis of cases. Mycopathologia. 2017 Dec; 182(11–12):1045–1052. https://doi.org/10.1007/s11046-017-0180-2Drogari-ApiranthitouMAnyfantisIGalaniIKaniouraLDaikosGLPetrikkosGAssociation between candiduria and candidemia: A clinical and molecular analysis of casesMycopathologia2017Dec18211–1210451052https://doi.org/10.1007/s11046-017-0180-210.1007/s11046-017-0180-228744769Search in Google Scholar
Eggimann P, Que YA, Revelly JP, Pagani JL. Preventing invasive candida infections. Where could we do better? J Hosp Infect. 2015 Apr;89(4):302–308. https://doi.org/10.1016/j.jhin.2014.11.006EggimannPQueYARevellyJPPaganiJLPreventing invasive candida infectionsWhere could we do better? J Hosp Infect2015Apr894302308https://doi.org/10.1016/j.jhin.2014.11.00610.1016/j.jhin.2014.11.00625592726Search in Google Scholar
Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist. 2017 Sep;10:204–212. https://doi.org/10.1016/j.jgar.2017.06.013EspositoSDeSimone GBocciaGDeCaro FPaglianoPSepsis and septic shock: New definitions, new diagnostic and therapeutic approachesJ Glob Antimicrob Resist2017Sep10204212https://doi.org/10.1016/j.jgar.2017.06.01310.1016/j.jgar.2017.06.01328743646Search in Google Scholar
Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009 May;37(5):1649–1654. https://doi.org/10.1097/CCM.0b013e31819def97JonesAETrzeciakSKlineJAThe Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentationCrit Care Med2009May37516491654https://doi.org/10.1097/CCM.0b013e31819def9710.1097/CCM.0b013e31819def97270372219325482Search in Google Scholar
Kasper L, König A, Koenig PA, Gresnigt MS, Westman J, Drummond RA, Lionakis MS, Groß O, Ruland J, Naglik JR, et al. The fungal peptide toxin candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes. Nat Commun. 2018 Dec;9(1):4260. https://doi.org/10.1038/s41467-018-06607-1KasperLKönigAKoenigPAGresnigtMSWestmanJDrummondRALionakisMSGroßORulandJNaglikJRet alThe fungal peptide toxin candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytesNat Commun2018Dec914260https://doi.org/10.1038/s41467-018-06607-110.1038/s41467-018-06607-1618914630323213Search in Google Scholar
Kauffman CA. Candiduria. Clin Infect Dis. 2005 Sep 15;41 Supplement_6:S371–S376. https://doi.org/10.1086/430918KauffmanCACandiduriaClin Infect Dis2005Sep 15;41 Supplement_6:S371–S376https://doi.org/10.1086/43091810.1086/43091816108001Search in Google Scholar
Kayaaslan B, Eser F, Kaya Kalem A, Bilgic Z, Asilturk D, Hasanoglu I, Ayhan M, Tezer Tekce Y, Erdem D, Turan S, et al. Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients. Mycoses. 2021 Sep;64(9):1083–1091. https://doi.org/10.1111/myc.13332KayaaslanBEserFKayaKalem ABilgicZAsilturkDHasanogluIAyhanMTezerTekce YErdemDTuranSet alCharacteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patientsMycoses2021Sep64910831091https://doi.org/10.1111/myc.1333210.1111/myc.13332824276934085319Search in Google Scholar
Kayaaslan B, Kaya Kalem A, Asilturk D, Kaplan B, Dönertas G, Hasanoglu I, Eser F, Korkmazer R, Oktay Z, Ozkocak Turan I, et al. Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients. Mycoses. 2022 May;65(5):508–516. https://doi.org/10.1111/myc.13431KayaaslanBKayaKalem AAsilturkDKaplanBDönertasGHasanogluIEserFKorkmazerROktayZOzkocakTuran Iet alIncidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patientsMycoses2022May655508516https://doi.org/10.1111/myc.1343110.1111/myc.13431911526935156742Search in Google Scholar
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985; 13(10):818–829. https://doi.org/10.1097/00003246-198510000-00009KnausWADraperEAWagnerDPZimmermanJEAPACHE II: A severity of disease classification systemCrit Care Med19851310818829https://doi.org/10.1097/00003246-198510000-0000910.1097/00003246-198510000-00009Search in Google Scholar
Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, |Malachias S, Vrettou C, Nichlos C, Kanavou A, Zervakis D, et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect. 2021 Jan;107:95–97. https://doi.org/10.1016/j.jhin.2020.11.009KokkorisSPapachatzakisIGavrielatouENtaidouTIschakiE|MalachiasSVrettouCNichlosCKanavouAZervakisDet alICU-acquired bloodstream infections in critically ill patients with COVID-19J Hosp Infect2021Jan1079597https://doi.org/10.1016/j.jhin.2020.11.00910.1016/j.jhin.2020.11.009767192633217490Search in Google Scholar
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924LaiCCShihTPKoWCTangHJHsuehPRSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInt J Antimicrob Agents2020Mar553105924https://doi.org/10.1016/j.ijantimicag.2020.10592410.1016/j.ijantimicag.2020.105924712780032081636Search in Google Scholar
Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C, Ripa M, Canetti D, Castiglioni B, Oltolini C, et al.; COVID-BioB Study Group. Candidemia in coronavirus disease 2019 (COVID-19) patients: Incidence and characteristics in a prospective cohort compared with historical Non-COVID-19 Controls. Clin Infect Dis. 2021 Nov 02;73(9):e2838–e2839. https://doi.org/10.1093/cid/ciaa1594MastrangeloAGerminarioBNFerranteMFrangiCLiVoti RMucciniCRipaMCanettiDCastiglioniBOltoliniCet alCOVID-BioB Study Group. Candidemia in coronavirus disease 2019 (COVID-19) patients: Incidence and characteristics in a prospective cohort compared with historical Non-COVID-19 ControlsClin Infect Dis2021Nov 02;739e2838e2839https://doi.org/10.1093/cid/ciaa159410.1093/cid/ciaa1594766542333124650Search in Google Scholar
Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12(1):204. https://doi.org/10.1186/cc6212MéanMMarchettiOCalandraTBench-to-bedside review: Candida infections in the intensive care unitCrit Care2008121204https://doi.org/10.1186/cc621210.1186/cc6212237459018279532Search in Google Scholar
Mermutluoglu C, Deveci O, Dayan S, Aslan E, Bozkurt F, Tekin R. Antifungal susceptibility and risk factors in patients with candidemia. Eurasian J Med. 2016 Jan 19;48(3):199–203. https://doi.org/10.5152/eurasianmed.2016.0021MermutluogluCDeveciODayanSAslanEBozkurtFTekinRAntifungal susceptibility and risk factors in patients with candidemiaEurasian J Med2016Jan 19483199203https://doi.org/10.5152/eurasianmed.2016.002110.5152/eurasianmed.2016.0021526860328149146Search in Google Scholar
Niyas VK, Rahulan SD, Arjun R, Sasidharan A. ICU-acquired candidemia in COVID-19 patients: An experience from a tertiary care hospital in Kerala, South India. Indian J Crit Care Med. 2021 Oct;25(10):1207–1208. https://doi.org/10.5005/jp-journals-10071-23980NiyasVKRahulanSDArjunRSasidharanAICU-acquired candidemia in COVID-19 patients: An experience from a tertiary care hospital in Kerala, South IndiaIndian J Crit Care Med2021Oct251012071208https://doi.org/10.5005/jp-journals-10071-2398010.5005/jp-journals-10071-23980864582534916760Search in Google Scholar
Nucci M, Barreiros G, Guimarães LF, Deriquehem VAS, Castiñeiras AC, Nouér SA. Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic. Mycoses. 2021 Feb; 64(2):152–156. https://doi.org/10.1111/myc.13225NucciMBarreirosGGuimarãesLFDeriquehemVASCastiñeirasACNouérSAIncreased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemicMycoses2021Feb642152156https://doi.org/10.1111/myc.1322510.1111/myc.13225775349433275821Search in Google Scholar
Omrani AS, Koleri J, Ben Abid F, Daghfel J, Odaippurath T, Peediyakkal MZ, Baiou A, Sarsak E, Elayana M, Kaleeckal A, et al. Clinical characteristics and risk factors for COVID-19-associated Candidemia. Med Mycol. 2021 Dec 03;59(12):1262–1266. https://doi.org/10.1093/mmy/myab056OmraniASKoleriJBenAbid FDaghfelJOdaippurathTPeediyakkalMZBaiouASarsakEElayanaMKaleeckalAet alClinical characteristics and risk factors for COVID-19-associated CandidemiaMed Mycol2021Dec 03591212621266https://doi.org/10.1093/mmy/myab05610.1093/mmy/myab05634625808Search in Google Scholar
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1–e50. https://doi.org/10.1093/cid/civ933PappasPGKauffmanCAAndesDRClancyCJMarrKAOstrosky-ZeichnerLReboliACSchusterMGVazquezJAWalshTJet alClinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of AmericaClin Infect Dis2016Feb 15624e1e50https://doi.org/10.1093/cid/civ93310.1093/cid/civ933472538526679628Search in Google Scholar
Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020 Nov 01;71(9):2459–2468. https://doi.org/10.1093/cid/ciaa530RawsonTMMooreLSPZhuNRanganathanNSkolimowskaKGilchristMSattaGCookeGHolmesABacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribingClin Infect Dis2020Nov 0171924592468https://doi.org/10.1093/cid/ciaa53010.1093/cid/ciaa530719759632358954Search in Google Scholar
Revankar SG, Hasan MS, Revankar VS, Sobel JD. Long-term follow-up of patients with candiduria. Eur J Clin Microbiol Infect Dis. 2011 Feb;30(2):137–140. https://doi.org/10.1007/s10096-010-1061-5RevankarSGHasanMSRevankarVSSobelJDLong-term follow-up of patients with candiduriaEur J Clin Microbiol Infect Dis2011Feb302137140https://doi.org/10.1007/s10096-010-1061-510.1007/s10096-010-1061-520857164Search in Google Scholar
Rotondo JC, Bononi I, Puozzo A, Govoni M, Foschi V, Lanza G, Gafà R, Gaboriaud P, Touzé FA, Selvatici R, et al. Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs, including anti-TNF. Clin Cancer Res. 2017 Jul 15;23(14):3929–3934. https://doi.org/10.1158/1078-0432.CCR-16-2899RotondoJCBononiIPuozzoAGovoniMFoschiVLanzaGGafàRGaboriaudPTouzéFASelvaticiRet alMerkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs, including anti-TNFClin Cancer Res2017Jul 15231439293934https://doi.org/10.1158/1078-0432.CCR-16-289910.1158/1078-0432.CCR-16-289928174236Search in Google Scholar
Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Tocilizumab: A therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch Med Res. 2020 Aug;51(6):595–597. https://doi.org/10.1016/j.arcmed.2020.05.009SahaASharmaARBhattacharyaMSharmaGLeeSSChakrabortyCTocilizumab: A therapeutic option for the treatment of cytokine storm syndrome in COVID-19Arch Med Res2020Aug516595597https://doi.org/10.1016/j.arcmed.2020.05.00910.1016/j.arcmed.2020.05.009724137432482373Search in Google Scholar
Seagle EE, Jackson BR, Lockhart SR, Georgacopoulos O, Nunnally NS, Roland J, Barter DM, Johnston HL, Czaja CA, Kayalioglu H, et al. The landscape of candidemia during the coronavirus disease 2019 (COVID-19) Pandemic. Clin Infect Dis. 2022 Mar 09;74(5):802–811. https://doi.org/10.1093/cid/ciab562SeagleEEJacksonBRLockhartSRGeorgacopoulosONunnallyNSRolandJBarterDMJohnstonHLCzajaCAKayaliogluHet alThe landscape of candidemia during the coronavirus disease 2019 (COVID-19) PandemicClin Infect Dis2022Mar 09745802811https://doi.org/10.1093/cid/ciab56210.1093/cid/ciab56234145450Search in Google Scholar
Segrelles-Calvo G, de S Araújo GR, Llopis-Pastor E, Carrillo J, Hernández-Hernández M, Rey L, Melean NR, Escribano I, Antón E, Zamarro C, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors. Respir Med. 2021 Nov;188:106619. https://doi.org/10.1016/j.rmed.2021.106619Segrelles-CalvoGde SAraújo GRLlopis-PastorECarrilloJHernández-HernándezMReyLMeleanNREscribanoIAntónEZamarroCet alCandida sppco-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors. Respir Med2021Nov188106619https://doi.org/10.1016/j.rmed.2021.10661910.1016/j.rmed.2021.106619844575934555702Search in Google Scholar
Vallabhaneni S, Chiller TM. Fungal infections and new biologic therapies. Curr Rheumatol Rep. 2016 May; 18(5):29. https://doi.org/10.1007/s11926-016-0572-1VallabhaneniSChillerTMFungal infections and new biologic therapiesCurr Rheumatol Rep2016May18529https://doi.org/10.1007/s11926-016-0572-110.1007/s11926-016-0572-127032792Search in Google Scholar
van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID- 19 patients: A systematic review and meta-analysis on clinical outcomes. Crit Care. 2020 Dec; 24(1):696. https://doi.org/10.1186/s13054-020-03400-9vanPaassen JVosJSHoekstraEMNeumannKMIBootPCArbousSMCorticosteroid use in COVID- 19 patients: A systematic review and meta-analysis on clinical outcomesCrit Care2020Dec241696https://doi.org/10.1186/s13054-020-03400-910.1186/s13054-020-03400-9773517733317589Search in Google Scholar
Villanueva-Lozano H, Treviño-Rangel RJ, González GM, Ramírez-Elizondo MT, Lara-Medrano R, Aleman-Bocanegra MC, Guajardo-Lara CE, Gaona-Chávez N, Castilleja-Leal F, Torre-Amione G, et al. Outbreak of Candida auris infection in a COVID- 19 hospital in Mexico. Clin Microbiol Infect. 2021 May;27(5):813–816. https://doi.org/10.1016/j.cmi.2020.12.030Villanueva-LozanoHTreviño-RangelRJGonzálezGMRamírez-ElizondoMTLara-MedranoRAleman-BocanegraMCGuajardo-LaraCEGaona-ChávezNCastilleja-LealFTorre-AmioneGet alOutbreak of Candida auris infection in a COVID- 19 hospital in MexicoClin Microbiol Infect2021May275813816https://doi.org/10.1016/j.cmi.2020.12.03010.1016/j.cmi.2020.12.030783565733429028Search in Google Scholar
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004 Aug 1;39(3):309–317. https://doi.org/10.1086/421946WisplinghoffHBischoffTTallentSMSeifertHWenzelRPEdmondMBNosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance studyClin Infect Dis2004Aug 1393309317https://doi.org/10.1086/42194610.1086/42194615306996Search in Google Scholar
Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID- 19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. https://doi.org/10.1016/j.ijantimicag.2020.105954ZhangCWuZLiJWZhaoHWangGQCytokine release syndrome in severe COVID- 19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortalityInt J Antimicrob Agents2020May555105954https://doi.org/10.1016/j.ijantimicag.2020.10595410.1016/j.ijantimicag.2020.105954711863432234467Search in Google Scholar